Zobrazeno 1 - 10
of 53
pro vyhledávání: '"L M, Cagen"'
Publikováno v:
Journal of Lipid Research, Vol 35, Iss 2, Pp 311-318 (1994)
We reported previously that dietary cholesterol produces hypertriglyceridemia in the rat, accompanied by reduced oxidation and increased incorporation of exogenous fatty acid into hepatic triglyceride and increased secretion of very low density lipop
Externí odkaz:
https://doaj.org/article/b9587a8d13714df88396c60ea3498787
Autor:
Ouyang, Shuyu1 (AUTHOR), Zhuo, Shu1 (AUTHOR), Yang, Mengmei1 (AUTHOR), Zhu, Tengfei2 (AUTHOR), Yu, Shuting1 (AUTHOR), Li, Yu1 (AUTHOR), Ying, Hao1 (AUTHOR), Le, Yingying1 (AUTHOR) yyle@sinh.ac.cn
Publikováno v:
Advanced Science. 12/11/2024, Vol. 11 Issue 46, p1-18. 18p.
Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat
Publikováno v:
Journal of lipid research. 42(12)
The corpulent JCR:LA-cp rat (cp/cp) is a useful model for study of the metabolic consequences of obesity and hyperinsulinemia. To assess the effect of hyperinsulinemia on VLDL secretion in this model, we measured rates of secretion of VLDL in perfuse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e341a9a0f507e2e3ca21c49472d3607a
https://pubmed.ncbi.nlm.nih.gov/11734577
https://pubmed.ncbi.nlm.nih.gov/11734577
Publikováno v:
Journal of Investigative Medicine. 52:S264
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e2bea1c384849e3c2847cf6a5823ed
https://doi.org/10.1097/00042871-200401001-00596
https://doi.org/10.1097/00042871-200401001-00596
Autor:
J. T. Crofton, L. Share, D. P. Brooks, Philip G. Baer, L. M. Cagen, A. Erman, Alberto Nasjletti
Publikováno v:
American Journal of Physiology-Renal Physiology. 248:F382-F388
This study was designed to investigate relationships between dietary potassium and the renal prostaglandin system in rats. The potassium content of the diet was 0.162 mmol/g during the control period and 0.004, 0.162, 1.351, or 2.702 mmol/g during th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8d5f6001a4946585b0042c0be59c03
https://doi.org/10.1152/ajprenal.1985.248.3.f382
https://doi.org/10.1152/ajprenal.1985.248.3.f382
Publikováno v:
Journal of Biological Chemistry. 251:6550-6554
When prostaglandin A1 was incubated with a Tris/saline suspension of washed human red blood cells, a substantial amount was converted to polar metabolites. These were purified by solvent extraction, XAD-2 column, and cellulose thin layer chromatograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::944ee948849e083b84247f90fdc261f7
https://doi.org/10.1016/s0021-9258(17)32982-4
https://doi.org/10.1016/s0021-9258(17)32982-4
Autor:
L M, Cagen, J J, Pisano
Publikováno v:
Biochimica et biophysica acta. 573(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::843c46c63173f16f0eed07399561c533
https://pubmed.ncbi.nlm.nih.gov/465519
https://pubmed.ncbi.nlm.nih.gov/465519
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 227(3)
In awake, male rats, oral theophylline (TH) or enprofylline (EN; 3-propyl xanthine), 10 to 50 mg/kg b.wt., similarly increased urinary prostaglandin (PG)E2 excretion, by 2- to 3-fold; urinary PGF2 alpha excretion was increased to a lesser extent (50%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fff5c457db2b8e5c6b0800b15ea98485
https://pubmed.ncbi.nlm.nih.gov/6581288
https://pubmed.ncbi.nlm.nih.gov/6581288
Publikováno v:
Prostaglandins. 32(2)
Studies were conducted to determine whether prostaglandins are added to the urine during its passage through the rat urinary bladder in vivo. Control rats and rats with chronic streptozotocin-induced diabetes were anesthetized with Inactin, 100 mg/kg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2405c1b4390c59d747c1f76d805fd879
https://pubmed.ncbi.nlm.nih.gov/3467393
https://pubmed.ncbi.nlm.nih.gov/3467393
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 9(3)
Systemic administration of platelet activating factor (PAF; acetyl glyceryl ether phosphorylcholine) reduces renal blood flow, but the mechanism responsible for that effect has not been defined. To address that problem, we determined the effects on r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f98be0aa2864d90f34bf2e34f00042
https://pubmed.ncbi.nlm.nih.gov/3818022
https://pubmed.ncbi.nlm.nih.gov/3818022